MedPath

Acute alerting effects of daytime exposure to specific wavelengths of light

Recruiting
Conditions
Primary health condition: Alertness and psychomotor vigilance in healthy human volunteers.
Mental Health - Studies of normal psychology, cognitive function and behaviour
Registration Number
ACTRN12608000142336
Lead Sponsor
Monash University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

(1) Male and female adults aged 18 to 30 years inclusive
(2) Healthy

Exclusion Criteria

(1) Individuals who have engaged in shiftwork/nightwork in the past 3 years and/or transmeridian travel in the past 3 months.
(2) Individuals who smoke, report high caffeine intake and/or high alcohol consumption.
(3) Individuals who screen positive for drugs of abuse following comprehensive urine toxicological analysis.
(4) Women who are pregnant, lactating or planning to become pregnant during the study period.
(5) A history of alcohol/drug dependence.
(6) Current, recent (<3 months) or chronic history of use of drugs or medication that affect the central nervous system (except non-steroid topical creams, oral contraceptives and occasional use of mild pain killers.
(7) History of psychiatric illness.
(8) Recent acute or chronic medical illness.
(9) Abnormal sleep patterns/sleep disorders.
(10) Auditory defects.
(11) Any form of photophobia including drug-induced, epilepsy, seizures, vertigo or migraine.
(12) Individuals with diseases of the visual system.
(13) Females who are not taking a medically approved form of birth control.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Psychomotor Vigilance Task mean reaction time (msec).[During and immediately after light exposure, expressed relative to baseline (i.e. immediately before light exposure).]
Secondary Outcome Measures
NameTimeMethod
Subjective sleepiness rating on the Karolinska Sleepiness Scale.[During and immediately after light exposure, expressed relative to baseline (i.e. immediately before light exposure).]
© Copyright 2025. All Rights Reserved by MedPath